Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial
Thromb Res
.
2026 Mar:259:109631.
doi: 10.1016/j.thromres.2026.109631.
Epub 2026 Feb 26.
Authors
Toru Sato
1
,
Yoshito Ogihara
2
,
Yugo Yamashita
3
,
Takeshi Morimoto
4
,
Nao Muraoka
5
,
Wataru Shioyama
6
,
Ryuki Chatani
7
,
Tatsuhiro Shibata
8
,
Yuji Nishimoto
9
,
Kosuke Doi
10
,
Maki Oi
11
,
Taro Shiga
12
,
Daisuke Sueta
13
,
Kitae Kim
14
,
Yasuhiro Tanabe
15
,
Norimichi Koitabashi
16
,
Takuma Takada
17
,
Satoshi Ikeda
18
,
Hitoshi Nakagawa
19
,
Kengo Tsukahara
20
,
Masaaki Shoji
21
,
Jiro Sakamoto
22
,
Shinji Hisatake
23
,
Yutaka Ogino
24
,
Masashi Fujita
25
,
Naohiko Nakanishi
26
,
Tomohiro Dohke
27
,
Seiichi Hiramori
28
,
Ryuzo Nawada
29
,
Kazuhisa Kaneda
30
,
Koh Ono
3
,
Takeshi Kimura
31
,
Kaoru Dohi
1
;
ONCO PE Trial Investigators
Affiliations
1
Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
2
Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan. Electronic address: yoshito@med.mie-u.ac.jp.
3
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
4
Department of Clinical Epidemiology, Hyogo Medical University, Nishinomiya, Japan.
5
Division of Cardiology, Shizuoka Cancer Center, Shizuoka, Japan.
6
Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.
7
Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
8
Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
9
Division of Cardiology, Osaka General Medical Center, Osaka, Japan.
10
Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
11
Department of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan.
12
Department of Onco-Cardiology/Cardiovascular Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
13
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
14
Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
15
Department of Cardiology, St. Marianna University School of Medicine, Kawasaki, Japan.
16
Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
17
Institute of Advanced Biomedical Engineering and Science, Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
18
Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
19
Department of Cardiovascular Medicine, Nara Medical University, Nara, Japan.
20
Division of Cardiology, Fujisawa City Hospital, Fujisawa, Japan.
21
Department of Cardiovascular Medicine, National Cancer Center Hospital, Tokyo, Japan.
22
Department of Cardiology, Tenri Hospital, Tenri, Japan.
23
Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, Japan.
24
Department of Cardiology, Yokohama City University, Yokohama, Japan.
25
Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan.
26
Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
27
Division of Cardiology, Kohka Public Hospital, Koka, Japan.
28
Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
29
Department of Cardiology. Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
30
Department of Cardiovascular Medicine, Mitsubishi Kyoto Hospital, Kyoto, Japan.
31
Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
PMID:
41762931
DOI:
10.1016/j.thromres.2026.109631
No abstract available
Publication types
Letter